The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | How genomic testing has influenced treatment approaches and clinical trial design in MPNs
Raajit Rampal
• 26 Aug 2022
In this video, Raajit Rampal, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, briefly discusses the growing role of genomic testing in myeloproliferative neoplasms (MPNs), and further emphasizes how genomic testing has influenced risk stratification, treatment, and clinical trial design in the field. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
